Výsledky vyhledávání - "Risperidone long-acting injection"

Akademický článek

Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study

Autor: Hikaru Hori, Asuka Katsuki, Kiyokazu Atake, Reiji Yoshimura

Publikováno v: Frontiers in Psychiatry, Vol 9 (2018)

ObjectivesRisperidone is the first new generation antipsychotic drug to become available as a long-acting injection (LAI). The purpose of this study was to evaluate the effects of switching from oral risperidone to risperidone LAI (RLAI) on cognitive

Externí odkaz: https://doaj.org/article/14105338f6d543d2b852910605e77ce8

Zobrazit plný text záznamu

Efficacy and Safety Profile of Risperidone Long-acting Injection in Adolescents in a Real-life Setting

Autor: Eyüp Sabri Ercan, Ulku Akyol Ardic, Sevim Berrin Inci, Mustafa Küçükköse

Publikováno v: Clinical Psychopharmacology and Neuroscience

WOS: 000425540200007
PubMed ID: 29397667
Objective: Risperidone long-acting injection (RLAI) was shown to be an alternative option in adult patients, but there is not available data in child and adolescents about this medication. The aim of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::697cc0154bc5ca0fce6c845f146757bb
https://doi.org/10.9758/cpn.2018.16.1.57

Zobrazit plný text záznamu

The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot Trial

Autor: Keiichiro Nishida, Masaki Kato, Yosuke Koshikawa, Chiara Fabbri, Naotaka Sunada, Yoshiteru Takekita, Toshihiko Kinoshita, Alessandro Serretti, Masafumi Yoshimura, Ai Onohara, Shiho Sakai

Publikováno v: Neuropsychobiology. 73:35-42

Purpose: The aim of this study was to compare the effects of risperidone long-acting injection (RLAI) and paliperidone palmitate (PP) on non-acute-phase social functioning in patients with schizophrenia. Patients and Methods: In this 6-month pilot, o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::681328c26dd86e40102fe5e63fc3d275
https://doi.org/10.1159/000442209

Zobrazit plný text záznamu

Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study

Autor: Reiji Yoshimura, Asuka Katsuki, Kiyokazu Atake, Hikaru Hori

Publikováno v: Frontiers in Psychiatry
Frontiers in Psychiatry, Vol 9 (2018)

Objectives: Risperidone is the first new generation antipsychotic drug to become available as a long-acting injection (LAI). The purpose of this study was to evaluate the effects of switching from oral risperidone to risperidone LAI (RLAI) on cogniti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf9cad8017ce71229c3c1f05d5b360ec
https://doi.org/10.3389/fpsyt.2018.00074

Zobrazit plný text záznamu

Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: A 6-month, open-label, randomized, pilot trial

Autor: Shiho Sakai, Keiichiro Nishida, Masaki Kato, Masafumi Yoshimura, Ai Onohara, Chiara Fabbri, Naotaka Sunada, Yoshiteru Takekita, Toshihiko Kinoshita, Alessandro Serretti, Yosuke Koshikawa

Publikováno v: BMC Psychiatry

Background Recently, long-acting injection (LAI) of second-generation antipsychotics has become a valuable strategy for the treatment of schizophrenia. However, few studies have compared the effects of different LAI antipsychotics on cognitive functi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44d5d2ccbf3c6185092a8b19c5b124d7
http://hdl.handle.net/11585/585592

Zobrazit plný text záznamu

Relapse and Long-Acting Injectable Risperidone: A 1-Year Mirror Image Study with a National Claims Database in Taiwan

Autor: Kuan-Pin Su, Hui Chih Chang, Chao Hsiun Tang, Feng Chang Yen, Shih-Jen Tsai

Publikováno v: Value in Health. 12:S118-S121

Objectives: The development of long-acting, injectable atypical antipsychotics has provided a new paradigm for schizophrenia treatment. The study was designed to assess whether a risperidone long-acting injection (RLAI) is associated with reduced rel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff61e7c5f36ec5746f2963719351c93c
https://doi.org/10.1111/j.1524-4733.2009.00643.x

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání